Search

Search Results

• ON THE VERSATILITY OF VON WILLEBRAND FACTOR

  Antoine Rauch, Peter Lenting

  e2013046

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.046

  2945

  PDF: 1193

  HTML: 11423

• PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

  Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro

  e2013058

  2013-09-01

  https://doi.org/10.4084/mjhid.2013.058

  3587

  PDF: 1212

  HTML: 24262

• VON WILLEBRAND FACTOR ABNORMALITIES STUDIED IN THE MOUSE MODEL: WHAT WE LEARNED ABOUT VWF FUNCTIONS

  Caterina Casari, Cecile V Denis

  e2013047

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.047

  2265

  PDF: 1001

  HTML: 9682

• CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

  Giancarlo Castaman

  e2013052

  2013-07-16

  https://doi.org/10.4084/mjhid.2013.052

  3297

  PDF: 1094

  HTML: 8606

• MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION

  Maimiza Zahari, Siti Aishah Sulaiman, Zulhabri Othman, Yasmin Ayob, Faraizah Abd Karim, Rahman Jamal

  e2018056

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.056

  2154

  PDF: 1102

  HTML: 970

  Figure 1: 194

  Figure 2: 211

• VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS

  Anna M. Randi, Mike A Laffan, Richard D. Starke

  e2013060

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.060

  3902

  PDF: 1648

  HTML: 8240

  Randi Fig: 209

• DISCOVERY OF TYPE 3 VON WILLEBRAND DISEASE IN A COHORT OF PATIENTS WITH SUSPECTED HEMOPHILIA A IN CÔTE D’IVOIRE

  Adia Eusèbe Adjambri, Sylvie Bouvier, Roseline N'guessan, Emma N’draman-Donou, Mireille Yayo-Ayé, Marie-France Meledje, Missa Louis Adjé, Duni Sawadogo

  e2020019

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.019

  1622

  PDF: 1298

  HTML: 281

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  2252

  PDF: 1997

  HTML: 527

• THE ROLE OF BLEEDING HISTORY AND CLINICAL MARKERS FOR THE CORRECT DIAGNOSIS OF VWD

  Alberto Tosetto

  e2013051

  2013-07-12

  https://doi.org/10.4084/mjhid.2013.051

  2556

  PDF: 944

  HTML: 4162

• EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS

  Marta E Martinuzzo

  e2016037

  2016-08-16

  https://doi.org/10.4084/mjhid.2016.037

  3202

  PDF: 1026

  HTML: 1956

  Untitled: 195

  Untitled: 214

  Untitled: 194

  Untitled: 214

  Untitled: 197

• Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

  Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith

  e2017034

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.034

  2753

  PDF: 1084

  HTML: 1214

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3526

  PDF: 1668

  HTML: 695

• SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

  Galila F Zaher, Soheir S Adam

  e2012021

  2012-04-02

  https://doi.org/10.4084/mjhid.2012.021

  1403

  PDF: 949

  HTML: 3630

• THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

  Evi Stavrou, Hillard Michael Lazarus

  e2010033

  2010-10-29

  https://doi.org/10.4084/mjhid.2010.033

  1704

  PDF: 1119

  HTML: 10763

• PATIENTS REFERRED FOR BLEEDING SYMPTOMS OF UNKNOWN CAUSE: DOES EVALUATION OF THROMBIN GENERATION CONTRIBUTE TO DIAGNOSIS?

  Elena Holm, Eva Zetterberg, Susanna Lövdahl, Erik Berntorp

  e2016014

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.014

  3859

  PDF: 873

  HTML: 1606

• CIRCUMCISION IN MALES WITH BLEEDING DISORDERS

  Hassan Mansouritorghabeh, Abdollah Banihashem, Alireza Modaresi, Lida Manavifar

  e2013004

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.004

  2032

  PDF: 963

  HTML: 6830

  Cover letter: 185

• PLATELET-LEUKOCYTE INTERACTIONS : MULTIPLE LINKS BETWEEN INFLAMMATION , BLOOD COAGULATION AND VASCULAR RISK

  Chiara Cerletti, Giovanni de Gaetano, Roberto Lorenzet

  e2010023

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.023

  1903

  PDF: 929

  HTML: 10545

• VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

  Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini

  e2009033

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.033

  2725

  PDF: 544

  HTML: 3610

• THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

  Nicola Semeraro, Prof. Mario Colucci

  e2021045

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.045

  2377

  PDF: 860

  HTML: 470

• INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

  M. Al Huneini, Anil Pathare

  e2017028

  2017-04-20

  https://doi.org/10.4084/mjhid.2017.028

  2228

  PDF: 969

  HTML: 1500

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  4606

  PDF: 1530

  HTML: 8541

• CLINICAL SIGNIFICANCE OF ASSESSMENT OF THROMBOSPONDIN AND PLACENTA GROWTH FACTOR LEVELS IN PATIENTS WITH SICKLE CELL ANEMIA: TWO CENTERS EGYPTIAN STUDIES

  adel abd elhaleim hagag, Ghada Elmashad, Aml Ezzat Abd El-Lateef

  e2014044

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.044

  1905

  PDF: 963

  HTML: 2311

• DESCRIPTIVE EPIDEMIOLOGY OF HEMOPHILIA AND OTHER COAGULATION DISORDERS IN MANSOURA , EGYPT

  Youssef Al Tonbary, Rasha ElAshry, Maysaa El Sayed Zaki

  e2010025

  2010-08-03

  https://doi.org/10.4084/mjhid.2010.025

  1828

  PDF: 971

  HTML: 1122

• PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

  Anna Falanga, Laura Russo, Carmen J Tartari

  e2011068

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.068

  1945

  PDF: 860

  HTML: 10360

  Figures 1,2,3: 231

• VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF

  sameh samir fahmey, Hassan Naguib, sanna Abdelshafy, rasha Alashry

  e2013044

  2013-06-05

  https://doi.org/10.4084/mjhid.2013.044

  1397

  PDF: 905

  HTML: 1133

  Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 215

• IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

  Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria

  e2024060

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.060

  2568

  PDF: 1954

  HTML: 178

• MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS

  Mrinalini kotru, Deepti Mutereja, Abhishek Purohit, Seema Tyagi, Manoranjan Mahapatra, Renu Saxena, Hara Prasad Pati

  e2016049

  2016-10-17

  https://doi.org/10.4084/mjhid.2016.049

  3397

  PDF: 764

  HTML: 768

  Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 226

  Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 222

  Table : Distribution of the sites of bleeding and their causes: 208

• DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura

  Yi Liu, Fan Lu, Binbin Ji, Wei Song, Hui Shen, Yingjie Xu, bining Yang

  e2026019

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.019

  895

  PDF: 765

  HTML: 239

• PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD

  Beatrice Autino, Yolanda Corbett, Francesco Castelli, Donatella Taramelli

  e2012061

  2012-10-04

  https://doi.org/10.4084/mjhid.2012.061

  4702

  PDF: 2001

  HTML: 18167

• Microangiopathic Hemolytic Anemia in 57-year-old woman with Borderline Serous Tumor of the Ovary:Real-Time Management of Common Pathways of Hemostatic Failure

  Gloria Joan Morris

  e2012030

  2012-05-06

  https://doi.org/10.4084/mjhid.2012.030

  1293

  PDF: 869

  HTML: 12875

• SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

  Firas Kreidieh, Sally Temraz

  e2020078

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.078

  1424

  PDF: 1006

  HTML: 446

• Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia

  Jérôme Guison, Gilles Blaison, Oana Stoica, Remy Hurstel, Marie Favier, Remi Favier

  e2017038

  2017-06-16

  https://doi.org/10.4084/mjhid.2017.038

  2346

  PDF: 875

  HTML: 971

  Patient’s family tree: 204

• PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Adel Abd Elhaleim Hagag

  e2014029

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.029

  1441

  PDF: 838

  HTML: 2374

• Intracardiac thrombosis in the three-year-old boy with normal left ventricle systolic function in MIS-C associated with COVID-19

  Stasa Krasic, Sasa Popovic, Ruzica Kravljanac, Sergej Prijic, Vladislav Vukomanovic

  e2022028

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.028

  939

  PDF: 491

  HTML: 276

• FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY

  Oshrat E. Tayer-Shifman, Eldad Ben-Chetrit

  e2011017

  2011-05-15

  https://doi.org/10.4084/mjhid.2011.017

  1294

  PDF: 749

  HTML: 1261

• PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

  Lucia De Franceschi

  e2009024

  2009-12-26

  1124

  PDF: 676

  HTML: 11188

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

  Michele Bibas, Shayna Sarosiek, Jorge J. Castillo

  e2024061

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.061

  3101

  PDF: 3356

  HTML: 754

• NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

  Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi

  e2019002

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.002

  7114

  PDF: 3773

  HTML: 818

• MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER

  Paola Ranalli, Stefano Baldoni, Daniela Bruno, Mauro Di Ianni

  e2024067

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.067

  1270

  PDF: 694

  Html: 191

• BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

  Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

  e2016011

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.011

  4455

  PDF: 1536

  HTML: 3729

• Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

  Maria Cristina Rapanotti

  e2018059

  2018-10-30

  https://doi.org/10.4084/mjhid.2018.059

  1411

  PDF: 837

  HTML: 207

• Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child

  aida borgi

  e2013041

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.041

  1219

  PDF: 680

  HTML: 1756

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  3040

  PDF: 1157

  HTML: 4679

• COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

  M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher

  e2009029

  2009-12-28

  1285

  PDF: 510

  HTML: 8307

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2621

  PDF: 1768

  HTML: 600

• Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?

  Amir Kuperman

  e2010031

  2010-10-01

  https://doi.org/10.4084/mjhid.2010.031

  1255

  PDF: 828

  HTML: 1792

• THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti

  e2013027

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.027

  2298

  PDF: 1070

  HTML: 2743